James Bridges
Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 28 | 2026 | 4106 | 1.880 |
Why?
| | Receptors, G-Protein-Coupled | 7 | 2026 | 231 | 1.400 |
Why?
| | Pulmonary Surfactants | 7 | 2025 | 105 | 1.300 |
Why?
| | Alveolar Epithelial Cells | 5 | 2021 | 121 | 1.110 |
Why?
| | Respiratory Mucosa | 5 | 2025 | 322 | 1.000 |
Why?
| | Pulmonary Alveolar Proteinosis | 4 | 2024 | 17 | 1.000 |
Why?
| | Glucocorticoids | 6 | 2023 | 531 | 0.890 |
Why?
| | Signal Transduction | 16 | 2026 | 5216 | 0.880 |
Why?
| | Pulmonary Alveoli | 7 | 2025 | 385 | 0.840 |
Why?
| | Betamethasone | 5 | 2023 | 21 | 0.820 |
Why?
| | Idiopathic Pulmonary Fibrosis | 3 | 2026 | 692 | 0.770 |
Why?
| | Epithelial Cells | 7 | 2026 | 1131 | 0.760 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2019 | 910 | 0.730 |
Why?
| | Transduction, Genetic | 2 | 2021 | 132 | 0.690 |
Why?
| | Dependovirus | 2 | 2021 | 78 | 0.690 |
Why?
| | Mice | 34 | 2026 | 18329 | 0.640 |
Why?
| | Animals | 52 | 2026 | 38030 | 0.640 |
Why?
| | Regeneration | 2 | 2021 | 197 | 0.620 |
Why?
| | Lipid Metabolism | 3 | 2024 | 529 | 0.610 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2017 | 161 | 0.600 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 296 | 0.530 |
Why?
| | Cell Adhesion | 2 | 2016 | 451 | 0.510 |
Why?
| | Lung Diseases | 4 | 2018 | 780 | 0.500 |
Why?
| | Cell Differentiation | 5 | 2023 | 2046 | 0.450 |
Why?
| | Fibroblasts | 4 | 2026 | 1025 | 0.430 |
Why?
| | Sterol Regulatory Element Binding Proteins | 1 | 2014 | 3 | 0.420 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 5 | 2021 | 45 | 0.420 |
Why?
| | Fetal Organ Maturity | 4 | 2022 | 13 | 0.410 |
Why?
| | Peptides | 3 | 2022 | 998 | 0.400 |
Why?
| | Dermatitis, Allergic Contact | 2 | 2026 | 73 | 0.370 |
Why?
| | Adrenal Cortex Hormones | 3 | 2020 | 484 | 0.370 |
Why?
| | Allergens | 3 | 2026 | 386 | 0.360 |
Why?
| | Cell Membrane | 1 | 2016 | 707 | 0.360 |
Why?
| | Lymphangiogenesis | 1 | 2011 | 27 | 0.350 |
Why?
| | Macrophages | 4 | 2024 | 1507 | 0.350 |
Why?
| | Models, Animal | 2 | 2019 | 393 | 0.340 |
Why?
| | Mice, Knockout | 9 | 2025 | 3124 | 0.330 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 456 | 0.330 |
Why?
| | Protein Folding | 4 | 2009 | 276 | 0.330 |
Why?
| | Macrophages, Alveolar | 6 | 2024 | 373 | 0.330 |
Why?
| | Morphogenesis | 2 | 2016 | 172 | 0.320 |
Why?
| | Liver | 3 | 2019 | 1896 | 0.320 |
Why?
| | 1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2010 | 5 | 0.320 |
Why?
| | Membrane Proteins | 3 | 2014 | 1164 | 0.320 |
Why?
| | Phospholipids | 2 | 2017 | 214 | 0.310 |
Why?
| | Cell Line | 9 | 2017 | 2823 | 0.300 |
Why?
| | Respiration | 1 | 2010 | 206 | 0.300 |
Why?
| | Genetic Vectors | 4 | 2021 | 335 | 0.300 |
Why?
| | Dexamethasone | 3 | 2020 | 365 | 0.290 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2025 | 107 | 0.280 |
Why?
| | Skin | 2 | 2026 | 753 | 0.280 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2378 | 0.270 |
Why?
| | Mice, Transgenic | 6 | 2017 | 2188 | 0.270 |
Why?
| | Lung Diseases, Interstitial | 2 | 2021 | 664 | 0.250 |
Why?
| | Smoothened Receptor | 1 | 2026 | 6 | 0.250 |
Why?
| | Perfume | 1 | 2026 | 5 | 0.240 |
Why?
| | GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2025 | 5 | 0.230 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2006 | 58 | 0.230 |
Why?
| | Pulmonary Fibrosis | 2 | 2024 | 395 | 0.230 |
Why?
| | Endoplasmic Reticulum | 4 | 2010 | 264 | 0.230 |
Why?
| | Sheep | 4 | 2023 | 876 | 0.230 |
Why?
| | One Health | 1 | 2025 | 10 | 0.230 |
Why?
| | Embryonic Development | 1 | 2026 | 125 | 0.230 |
Why?
| | Humans | 39 | 2026 | 145475 | 0.220 |
Why?
| | Vaping | 1 | 2026 | 74 | 0.220 |
Why?
| | Disinfectants | 1 | 2025 | 45 | 0.220 |
Why?
| | Hedgehog Proteins | 1 | 2026 | 200 | 0.220 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2026 | 239 | 0.210 |
Why?
| | Heat-Shock Proteins | 2 | 2008 | 139 | 0.200 |
Why?
| | Maternal Exposure | 1 | 2025 | 189 | 0.200 |
Why?
| | Prenatal Care | 3 | 2022 | 309 | 0.190 |
Why?
| | Eosinophils | 1 | 2025 | 316 | 0.190 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2019 | 155 | 0.190 |
Why?
| | Epigenomics | 1 | 2023 | 114 | 0.190 |
Why?
| | Lung Injury | 1 | 2026 | 244 | 0.190 |
Why?
| | Mutation | 7 | 2021 | 4075 | 0.180 |
Why?
| | Phosphatidylcholines | 2 | 2013 | 130 | 0.180 |
Why?
| | Gene Expression Profiling | 5 | 2019 | 1767 | 0.170 |
Why?
| | Employment | 1 | 2024 | 184 | 0.170 |
Why?
| | Adaptation, Physiological | 1 | 2025 | 560 | 0.170 |
Why?
| | Cytokine Receptor Common beta Subunit | 2 | 2018 | 2 | 0.170 |
Why?
| | Skin Irritancy Tests | 1 | 2020 | 4 | 0.160 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 5983 | 0.160 |
Why?
| | Disease Models, Animal | 8 | 2026 | 4560 | 0.160 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2021 | 155 | 0.160 |
Why?
| | Capsid | 1 | 2020 | 94 | 0.160 |
Why?
| | Odorants | 1 | 2020 | 114 | 0.150 |
Why?
| | Macaca mulatta | 4 | 2021 | 186 | 0.150 |
Why?
| | Exons | 3 | 2013 | 363 | 0.150 |
Why?
| | Premature Birth | 2 | 2020 | 388 | 0.150 |
Why?
| | Animals, Newborn | 4 | 2025 | 891 | 0.150 |
Why?
| | Medicaid | 1 | 2024 | 467 | 0.150 |
Why?
| | Cell Proliferation | 4 | 2020 | 2507 | 0.150 |
Why?
| | Heparin | 1 | 2020 | 247 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 652 | 0.140 |
Why?
| | Cholesterol | 2 | 2018 | 408 | 0.140 |
Why?
| | Receptors, Glucocorticoid | 1 | 2020 | 129 | 0.140 |
Why?
| | Gene Expression | 3 | 2017 | 1476 | 0.140 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2018 | 30 | 0.140 |
Why?
| | Amyloid | 1 | 2019 | 94 | 0.140 |
Why?
| | Amino Acids | 1 | 2022 | 519 | 0.140 |
Why?
| | Acyl-CoA Oxidase | 1 | 2018 | 2 | 0.140 |
Why?
| | Fetal Development | 1 | 2021 | 298 | 0.140 |
Why?
| | tau Proteins | 1 | 2019 | 105 | 0.140 |
Why?
| | Delivery, Obstetric | 1 | 2019 | 160 | 0.140 |
Why?
| | Memory Disorders | 1 | 2019 | 197 | 0.130 |
Why?
| | Lymphocytes | 1 | 2020 | 376 | 0.130 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2018 | 72 | 0.130 |
Why?
| | Erythroblasts | 1 | 2017 | 18 | 0.130 |
Why?
| | Receptors, Erythropoietin | 1 | 2017 | 21 | 0.130 |
Why?
| | Polycythemia | 1 | 2017 | 25 | 0.130 |
Why?
| | Lipids | 4 | 2024 | 707 | 0.130 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2020 | 317 | 0.130 |
Why?
| | Transgenes | 2 | 2011 | 190 | 0.130 |
Why?
| | Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 29 | 0.130 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 230 | 0.130 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2017 | 117 | 0.130 |
Why?
| | Immunohistochemistry | 3 | 2012 | 1716 | 0.130 |
Why?
| | Biomarkers | 5 | 2023 | 4295 | 0.120 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2018 | 141 | 0.120 |
Why?
| | Pregnancy | 7 | 2025 | 7202 | 0.120 |
Why?
| | Myelodysplastic Syndromes | 1 | 2018 | 165 | 0.120 |
Why?
| | Neovascularization, Physiologic | 2 | 2009 | 192 | 0.120 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 395 | 0.120 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2015 | 8 | 0.120 |
Why?
| | Genetic Diseases, Inborn | 1 | 2015 | 45 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 624 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2016 | 145 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2026 | 2028 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2017 | 638 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1923 | 0.110 |
Why?
| | Fetus | 1 | 2019 | 804 | 0.110 |
Why?
| | Transfection | 3 | 2009 | 926 | 0.110 |
Why?
| | Gene Deletion | 3 | 2019 | 391 | 0.110 |
Why?
| | Salivary Glands | 1 | 2014 | 36 | 0.100 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1454 | 0.100 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 443 | 0.100 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2018 | 372 | 0.100 |
Why?
| | Molecular Chaperones | 2 | 2008 | 199 | 0.100 |
Why?
| | Gene Knock-In Techniques | 2 | 2026 | 61 | 0.100 |
Why?
| | Respiratory Insufficiency | 1 | 2017 | 326 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2020 | 835 | 0.100 |
Why?
| | Receptors, Purinergic P2Y2 | 1 | 2013 | 4 | 0.100 |
Why?
| | Calcinosis | 1 | 2015 | 234 | 0.100 |
Why?
| | Cytomegalovirus | 1 | 2014 | 168 | 0.100 |
Why?
| | Apoptosis | 3 | 2026 | 2440 | 0.100 |
Why?
| | Hermanski-Pudlak Syndrome | 1 | 2012 | 2 | 0.090 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 2 | 2026 | 53 | 0.090 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 956 | 0.090 |
Why?
| | Consumer Product Safety | 2 | 2026 | 80 | 0.090 |
Why?
| | Analysis of Variance | 2 | 2012 | 1300 | 0.090 |
Why?
| | Computational Biology | 1 | 2017 | 669 | 0.090 |
Why?
| | Immune Sera | 1 | 2011 | 77 | 0.090 |
Why?
| | Internet | 1 | 2017 | 689 | 0.090 |
Why?
| | Glycogen | 1 | 2011 | 55 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2011 | 16 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2011 | 552 | 0.090 |
Why?
| | Myofibroblasts | 2 | 2026 | 148 | 0.090 |
Why?
| | Doxycycline | 1 | 2011 | 62 | 0.090 |
Why?
| | Luciferases | 3 | 2009 | 153 | 0.090 |
Why?
| | Liver Neoplasms | 1 | 2018 | 776 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2011 | 156 | 0.080 |
Why?
| | Immunoblotting | 1 | 2011 | 295 | 0.080 |
Why?
| | Female | 14 | 2026 | 78845 | 0.080 |
Why?
| | Protein Transport | 3 | 2012 | 442 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 337 | 0.080 |
Why?
| | Hypoxia | 1 | 2018 | 1199 | 0.080 |
Why?
| | DNA Primers | 1 | 2011 | 505 | 0.080 |
Why?
| | DNA, Mitochondrial | 1 | 2011 | 211 | 0.080 |
Why?
| | Air | 1 | 2010 | 44 | 0.080 |
Why?
| | Regulatory Factor X Transcription Factors | 2 | 2008 | 9 | 0.080 |
Why?
| | Receptors, Adenosine A2 | 1 | 2009 | 5 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 371 | 0.070 |
Why?
| | Injections, Intramuscular | 2 | 2019 | 146 | 0.070 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2008 | 25 | 0.070 |
Why?
| | Epitopes | 1 | 2010 | 473 | 0.070 |
Why?
| | Models, Biological | 2 | 2017 | 1764 | 0.070 |
Why?
| | Phenotype | 3 | 2017 | 3155 | 0.060 |
Why?
| | Binding Sites | 2 | 2026 | 1310 | 0.060 |
Why?
| | Homeostasis | 2 | 2023 | 642 | 0.060 |
Why?
| | Administration, Oral | 2 | 2019 | 866 | 0.060 |
Why?
| | Microscopy, Fluorescence | 2 | 2009 | 408 | 0.060 |
Why?
| | Mesocricetus | 1 | 2026 | 52 | 0.060 |
Why?
| | Risk Assessment | 3 | 2026 | 3747 | 0.060 |
Why?
| | Allosteric Regulation | 1 | 2026 | 99 | 0.060 |
Why?
| | Transcription Factors | 3 | 2017 | 1734 | 0.060 |
Why?
| | Arachidonic Acid | 1 | 2026 | 102 | 0.060 |
Why?
| | No-Observed-Adverse-Effect Level | 1 | 2026 | 7 | 0.060 |
Why?
| | Lysosomal-Associated Membrane Protein 1 | 1 | 2006 | 12 | 0.060 |
Why?
| | Leupeptins | 1 | 2006 | 13 | 0.060 |
Why?
| | Protein Sorting Signals | 1 | 2006 | 21 | 0.060 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2006 | 50 | 0.060 |
Why?
| | Cricetinae | 1 | 2026 | 305 | 0.060 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2006 | 23 | 0.060 |
Why?
| | Proteasome Inhibitors | 1 | 2006 | 41 | 0.060 |
Why?
| | I-kappa B Proteins | 1 | 2006 | 75 | 0.060 |
Why?
| | Blotting, Western | 2 | 2009 | 1179 | 0.060 |
Why?
| | Influenza A virus | 1 | 2026 | 119 | 0.060 |
Why?
| | Zoonoses | 1 | 2025 | 38 | 0.060 |
Why?
| | Protein Processing, Post-Translational | 1 | 2008 | 471 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2012 | 1149 | 0.060 |
Why?
| | Protein Binding | 3 | 2009 | 2238 | 0.050 |
Why?
| | Caspase 3 | 1 | 2006 | 242 | 0.050 |
Why?
| | Caspases | 1 | 2006 | 233 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1321 | 0.050 |
Why?
| | Promoter Regions, Genetic | 3 | 2019 | 1246 | 0.050 |
Why?
| | Blood Vessels | 1 | 2006 | 167 | 0.050 |
Why?
| | Male | 8 | 2026 | 72843 | 0.050 |
Why?
| | Dysbiosis | 1 | 2025 | 187 | 0.050 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2023 | 16 | 0.050 |
Why?
| | Oligopeptides | 1 | 2006 | 267 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2020 | 6447 | 0.050 |
Why?
| | Autophagy | 1 | 2026 | 291 | 0.050 |
Why?
| | Ligands | 1 | 2026 | 665 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2026 | 280 | 0.050 |
Why?
| | Actins | 1 | 2026 | 425 | 0.050 |
Why?
| | Down-Regulation | 1 | 2006 | 618 | 0.050 |
Why?
| | Hippocampus | 2 | 2019 | 971 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2026 | 226 | 0.050 |
Why?
| | Eligibility Determination | 1 | 2024 | 72 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 273 | 0.050 |
Why?
| | Endothelial Cells | 1 | 2009 | 874 | 0.050 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 1189 | 0.050 |
Why?
| | Pneumonia | 2 | 2020 | 636 | 0.050 |
Why?
| | Up-Regulation | 1 | 2006 | 847 | 0.050 |
Why?
| | Cell Survival | 1 | 2006 | 1100 | 0.050 |
Why?
| | History, 20th Century | 1 | 2024 | 328 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2008 | 1480 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2018 | 1443 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2003 | 376 | 0.040 |
Why?
| | Transcriptome | 2 | 2019 | 1038 | 0.040 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 56 | 0.040 |
Why?
| | Steroids | 1 | 2022 | 160 | 0.040 |
Why?
| | Lung Neoplasms | 2 | 2012 | 2664 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 524 | 0.040 |
Why?
| | Fibrosis | 1 | 2023 | 559 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2006 | 740 | 0.040 |
Why?
| | Sepharose | 1 | 2020 | 32 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2023 | 2769 | 0.040 |
Why?
| | Time Factors | 2 | 2019 | 7123 | 0.040 |
Why?
| | Health Policy | 1 | 2024 | 400 | 0.040 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 1 | 2020 | 8 | 0.040 |
Why?
| | Chorioamnionitis | 1 | 2020 | 50 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 977 | 0.040 |
Why?
| | Capsid Proteins | 1 | 2020 | 94 | 0.040 |
Why?
| | Receptor, IGF Type 1 | 1 | 2020 | 64 | 0.040 |
Why?
| | Cytokines | 2 | 2018 | 2067 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2023 | 2803 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2026 | 1356 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2003 | 728 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 628 | 0.040 |
Why?
| | Biological Availability | 1 | 2019 | 145 | 0.040 |
Why?
| | Diet | 2 | 2018 | 1277 | 0.040 |
Why?
| | Bronchoalveolar Lavage | 1 | 2018 | 89 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2019 | 428 | 0.030 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2020 | 344 | 0.030 |
Why?
| | Capillary Leak Syndrome | 1 | 2017 | 12 | 0.030 |
Why?
| | Inflammation | 2 | 2020 | 2878 | 0.030 |
Why?
| | Gene Order | 1 | 2017 | 29 | 0.030 |
Why?
| | Cell Death | 1 | 2019 | 382 | 0.030 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 60 | 0.030 |
Why?
| | Surface-Active Agents | 1 | 2018 | 98 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1891 | 0.030 |
Why?
| | RNA Interference | 2 | 2009 | 475 | 0.030 |
Why?
| | Point Mutation | 1 | 2018 | 240 | 0.030 |
Why?
| | Cell Count | 1 | 2017 | 319 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2017 | 277 | 0.030 |
Why?
| | DNA | 1 | 2003 | 1435 | 0.030 |
Why?
| | Hepatocytes | 1 | 2018 | 224 | 0.030 |
Why?
| | Erythropoietin | 1 | 2017 | 100 | 0.030 |
Why?
| | Neuronal Plasticity | 1 | 2019 | 305 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 178 | 0.030 |
Why?
| | Placenta | 1 | 2023 | 786 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2017 | 167 | 0.030 |
Why?
| | Gestational Age | 1 | 2019 | 987 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 287 | 0.030 |
Why?
| | Fear | 1 | 2019 | 368 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2017 | 506 | 0.030 |
Why?
| | Infant, Premature | 1 | 2020 | 619 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2017 | 418 | 0.030 |
Why?
| | Learning | 1 | 2019 | 443 | 0.030 |
Why?
| | Metabolome | 1 | 2018 | 388 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 443 | 0.030 |
Why?
| | Phosphates | 1 | 2015 | 177 | 0.030 |
Why?
| | Fatty Acids | 1 | 2018 | 457 | 0.030 |
Why?
| | Epithelium | 1 | 2015 | 310 | 0.030 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2020 | 411 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 506 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2017 | 784 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2017 | 480 | 0.030 |
Why?
| | Asthma | 1 | 2025 | 1797 | 0.030 |
Why?
| | Adaptor Protein Complex 3 | 1 | 2012 | 3 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1707 | 0.020 |
Why?
| | Developmental Disabilities | 1 | 2014 | 281 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1261 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2012 | 181 | 0.020 |
Why?
| | Software | 1 | 2017 | 680 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2012 | 330 | 0.020 |
Why?
| | Mitochondria | 1 | 2018 | 992 | 0.020 |
Why?
| | Bleomycin | 1 | 2012 | 255 | 0.020 |
Why?
| | Synapses | 1 | 2014 | 439 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 17291 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 506 | 0.020 |
Why?
| | Pneumonectomy | 1 | 2012 | 167 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2864 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 767 | 0.020 |
Why?
| | Microscopy, Immunoelectron | 1 | 2009 | 43 | 0.020 |
Why?
| | Amino Acids, Dicarboxylic | 1 | 2009 | 9 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2018 | 1996 | 0.020 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2009 | 49 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 139 | 0.020 |
Why?
| | Response Elements | 1 | 2009 | 86 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1374 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 319 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 1327 | 0.020 |
Why?
| | Valosin Containing Protein | 1 | 2008 | 8 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2009 | 247 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2597 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1547 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2008 | 105 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2008 | 148 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1471 | 0.020 |
Why?
| | Cytosol | 1 | 2008 | 213 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 159 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2012 | 1997 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 2121 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 749 | 0.010 |
Why?
| | United States | 1 | 2024 | 16098 | 0.010 |
Why?
| | Aged | 2 | 2018 | 26153 | 0.010 |
Why?
| | Cell Movement | 1 | 2009 | 959 | 0.010 |
Why?
| | Obesity | 1 | 2018 | 3116 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2008 | 630 | 0.010 |
Why?
| | Middle Aged | 2 | 2018 | 36215 | 0.010 |
Why?
| | Registries | 1 | 2012 | 2406 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5423 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4148 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 6013 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5584 | 0.010 |
Why?
| | Neoplasms | 1 | 2014 | 2906 | 0.010 |
Why?
| | Insulin | 1 | 2008 | 2512 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 11772 | 0.010 |
Why?
| | Adult | 1 | 2017 | 40777 | 0.010 |
Why?
|
|
Bridges's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|